Targovax logoTargovax logo

  • About
    About
      • About Targovax
      • Management Team
      • Board of Directors
      • Careers
  • Technology
    Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
  • Pipeline
    Pipeline
      • Our pipeline
      • Development Program
        • Melanoma
        • Mesothelioma
        • Collaboration Trials
        • New viruses
  • Partnering
  • Investors & Media
    Investors & Media
      • Our strategy
      • Press releases
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Events
      • Contact
      • Subscribe
  • Governance
    Governance
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
  • Contacts
    Contacts
      • Offices
      • Investors & Media
    • About
      • About Targovax
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • Technology
      • ONCOS – Oncolyctic Virus
      • Intellectual Property Rights
      • Publications
    • Pipeline
      • Our pipeline
      • Development program
    • Partnering
      • TG Mutant RAS neoantigen vaccine – Available for partnering
    • Investors & Media
      • Our strategy
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Financial Reports
      • Press releases
      • Presentations
      • Prospectus
      • Debt
      • Events
      • Subscribe
      • Contact
    • Governance
      • Corporate Governance Report
      • Corporate Social Responsibility Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
    • Contacts
      • Offices
      • Career
      • Investors & Media

    Extraordinary General Meeting October 2014

    October 30, 2014

    Extraordinary general assembly held October 2014

    An extraordinary general assembly of Targovax AS was held on Oct 30 2014 at 10.00 CET.

    Documents

    • Please find the protocol attached.
    • Please find the notice of the meeting attached
    IR contact
    Torbjørn Furuseth
    Torbjørn Furuseth
    CFO
    torbjorn.furuseth@targovax.com
    +47 932 11 101
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@targovax.com
    +47 922 61 624

    Annual Report 2019

    Published March 11, 2020.

    • Annual report 2019
    Archive financial reports

    Share

    • PRINT
    • STAY CONNECTED
    • Terms of use
    • Privacy policy

    This website uses cookies to ensure you get the best experience on our website. Learn More | Terms of Use

    Yes, I accept